Vectura Group plc

LSE (GBp): Vectura Group plc (VEC)

Last Price

164.80

Today's Change

0.00 (0.00%)

Day's Change

164.63 - 165.00

Trading Volume

203,762

Overview

Market Cap

0

Shares Outstanding

0

Avg Volume

8,295,809

Avg Price (50 Days)

164.61

Avg Price (200 Days)

145.48

PE Ratio

0.08

EPS

20.10

Earnings Announcement

Previous Close

164.80

Open

164.80

Day's Range

164.632 - 165.0

Year Range

100.0 - 176.0

Trading Volume

203,762

Price Change Highlight

1 Day Change

0.00%

5 Day Change

0.00%

1 Month Change

0.00%

3 Month Change

0.00%

6 Month Change

0.00%

Ytd Change

0.00%

1 Year Change

0.00%

3 Year Change

0.00%

5 Year Change

0.00%

10 Year Change

0.00%

Max Change

0.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—General

Description:

Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees. The firm's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment